about
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-bas...
Read More
5.50
0.12
(2.23%)
15.4M
XNAS Volume
High volume today
XNAS 23 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Altimmune Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..